Cardinal Health (FRA:CLH) Net Interest Margin (Bank Only) %


FRA:CLH Cardinal Health Inc FRA:CLH
81 GF Score
Price €207.00
GF Value €123.39
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cardinal Health Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:CLH
81GF Score
Cardinal Health Inc FRA:CLH
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cardinal Health (FRA:CLH) Overvalued in 2026?

Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued. The current stock price of €207.00 is trading 67.8% above its estimated GF Value™ of €123.39. GuruFocus considers Cardinal Health to be Significantly Overvalued.

Key valuation signals for FRA:CLH:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €123.39 vs. price of €207.00 (67.8% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the FRA:CLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cardinal Health Business Description

Address 7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score

Get the complete analysis for FRA:CLH

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€207.00
Price
€123.39
GF Value